User profiles for Siddharth Menon

Siddhartha Menon

- Verified email at namcodiversity.org - Cited by 105

Siddharth Menon

- Verified email at wisc.edu - Cited by 2

Skeletal stem and progenitor cells maintain cranial suture patency and prevent craniosynostosis

S Menon, A Salhotra, S Shailendra, R Tevlin… - Nature …, 2021 - nature.com
Cranial sutures are major growth centers for the calvarial vault, and their premature fusion
leads to a pathologic condition called craniosynostosis. This study investigates whether …

An overview of direct somatic reprogramming: the ins and outs of iPSCs

S Menon, S Shailendra, A Renda, M Longaker… - International journal of …, 2016 - mdpi.com
Stem cells are classified into embryonic stem cells and adult stem cells. An evolving alternative
to conventional stem cell therapies is induced pluripotent stem cells (iPSCs), which have …

Error detection and correction in semiconductor memories using 3D parity check code with hamming code

S Tambatkar, SN Menon, V Sudarshan… - 2017 International …, 2017 - ieeexplore.ieee.org
Data stored in memory or buffer needs Error Detection And Correction (EDAC). Errors occur
due to supply voltage fluctuations and/or noise due to electromagnetic interference or …

Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic review

…, A Balasubramanian, U Hafeez, S Menon… - Journal of neuro …, 2022 - Springer
Purpose Limited progress has been made in treating glioblastoma, and we hypothesise that
poor concordance between preclinical and clinical efficacy in this disease is a major barrier …

Concurrent versus sequential sorafenib therapy in combination with radiation for hepatocellular carcinoma

…, K Taparra, J Zeng, JA Cades, E Velarde, S Menon… - PloS one, 2013 - journals.plos.org
Sorafenib (SOR) is the only systemic agent known to improve survival for hepatocellular
carcinoma (HCC). However, SOR prolongs survival by less than 3 months and does not alter …

[HTML][HTML] Antibody-drug conjugates: beyond current approvals and potential future strategies

S Menon, S Parakh, AM Scott… - Exploration of targeted anti …, 2022 - ncbi.nlm.nih.gov
The recent approvals for antibody-drug conjugates (ADCs) in multiple malignancies in recent
years have fuelled the ongoing development of this class of drugs. These novel agents …

Identifying misinformation from website screenshots

S Abdali, R Gurav, S Menon, D Fonseca… - Proceedings of the …, 2021 - ojs.aaai.org
Can the look and the feel of a website give information about the trustworthiness of an article?
In this paper, we propose to use a promising, yet neglected aspect in detecting the …

SOUTH ASIAN URBAN CLIMATES: Towards Pluralistic Narratives and Expanded Lexicons

…, S Syal, DA Ghertner, SR Menon… - … Journal of Urban …, 2023 - Wiley Online Library
This Interventions essay presents 14 stories of, and positions on, urban climates in South
Asia. We look analytically and linguistically from this region to engage the terms ‘mahaul’, ‘…

Antibody drug conjugates for glioblastoma: current progress towards clinical use

…, L Cher, A Uccellini, U Hafeez, S Menon… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Antibody drug conjugates (ADCs) are now a proven therapeutic class for many
cancers, combining highly specific targeting with the potency of high effective payloads. This …

Machine learning based prognostic model and mobile application software platform for predicting infection susceptibility of COVID-19 using healthcare data

R Srivatsan, PN Indi, S Agrahari, S Menon… - Research on Biomedical …, 2020 - Springer
Introduction From public health perspectives of COVID-19 pandemic, accurate estimates of
infection severity of individuals are extremely valuable for the informed decision-making and …